Astellas Pharma Inc - Company Profile
Powered by 
All the data and insights you need on Astellas Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Astellas Pharma Inc Strategy Report
- Understand Astellas Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Astellas Pharma Catalyst Calendar
Proactively evaluate Astellas Pharma Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Astellas Pharma Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 30 Aug 2019 | Regulatory Approval (EU) | Astellas Pharma Inc | 4503 | gilteritinib fumarate | Oncology | Refractory Acute Myeloid Leukemia | GD Estimates |
| 30 Aug 2019 | Phase III Trial Initiation | Astellas Pharma Inc; European and Developing Countries Clinical Trials Partnership; Global Health Innovative Technology Fund; Institute of Pharmaceutical Technology; Kenya Medical Research Institute; Merck KGaA; SCI Foundation; Stichting Lygature; Swiss Tropical and Public Health Institute; University Felix Houphouet Boigny | 4503; MRK | L-Praziquantel | Infectious Disease | Schistosomiasis; Schistosomiasis mansoni Infections | Clinical Trial Registry |
| 20 Aug 2019 | Phase II Trial Completion | Astellas Pharma Inc; Memorial Sloan Kettering Cancer Center; National Cancer Institute US | 4503 | isavuconazonium sulfate; micafungin sodium | Infectious Disease; Oncology | Blood Cancer; Fungal Infections; Myeloproliferative Disorders | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer